Dr. Xiang-Cheng Li has a highly specialized practice focused on (1) Hepatobiliary malignancy, particularly patients with hepatocellular carcinoma and hilar cholangiocarcinoma, and (2) Liver transplantation, which involves living donor liver transplantation. Dr. Li is the vice director of Hepatobiliary Center, as well as professor of surgery at Nanjing Medical University. His particular area of clinical expertise is in the radical resection of advanced hilar cholangiocarcinoma and liver transplantation. He and his team performed the first living donor liver transplantation in the mainland of China. He was awarded the Best surgical video at the 2012 Conference of International Hepato-Pancreato-Biliary Association. So far, he has completed more than 300 cases of liver transplantation, 2000 cases of hepatectomy, and over 300 cases of hilar cholangiocarcinoma. Dr. Li is currently the Chairman of Oncology Society of Jiangsu province Medical Association and a member of Biliary Tract Surgery Committee of Chinese Medical Association. He is also a member of the Membership and Communications Committee of Liver Transplantation Society (ILTS) as well as a member of International Hepato-Pancreato-Biliary Association. He is a widely recognized expert of hepatobiliary surgery in China, and in addition to his clinical practice, Dr. Li runs many highly productive research programs focused on liver ischemia-reperfusion injury in liver transplantation, genomic characteristics of cholangiocarcinoma, and prognosis model of hepatobiliary malignancies, and has authored over 50 publications including Annals of Surgery, Annals of surgical oncology, J Immunother Cancer, Radiology, Journal of Hepatology, etc.